Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.
about
Evaluation Series on Safety and Efficacy of Nutritional Supplements in Newly Diagnosed Hyperglycemia: A Placebo-Controlled, Randomized Study.Effects of Low-Molecular-Weight Fucoidan and High Stability Fucoxanthin on Glucose Homeostasis, Lipid Metabolism, and Liver Function in a Mouse Model of Type II Diabetes.Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes.Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial.Developing a Clinical Diabetes Guideline in Diabetes Research Network in IranMicrovascular Complications and Their Associated Risk Factors in Newly Diagnosed Type 2 Diabetes Mellitus Patients.Linagliptin plus metformin in patients with newly diagnosed type 2 diabetes and marked hyperglycemia.Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals.Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 Diabetes.Effects of gliclazide add on metformin on serum omentin-1 levels in patients with type 2 diabetes mellitus.Prescribing practices and clinical predictors of glucose-lowering therapy within the first year in people with newly diagnosed Type 2 diabetes.Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to dateEffect of metformin on the incidence of head and neck cancer in diabetics.Initiating therapy in patients newly diagnosed with type 2 diabetes: Combination therapy vs a stepwise approach.
P2860
Q30386420-EC98758F-DF6E-4C6D-929C-14D2619FE28FQ33612248-61890FA6-8B15-4614-AD5C-E89390155C6BQ33652884-16A72D55-47BD-46DD-91EE-90A7C8F8FFCDQ33834266-9CDFAEAC-F007-4E51-9788-16C98D1E8536Q35763250-2D9BDA3C-589E-49ED-BE58-3B86FAF283DAQ36112535-D31C71BB-E3B1-48DD-A661-A2802EBCBE0BQ38387034-4A7EA123-E269-4A17-8C80-ADAA95B9E0F5Q38599975-5D415E70-B537-4B25-8BC2-A4C21AFAF72EQ38672852-277A3A31-361C-4424-BB3B-A0B6F09AC7F5Q39005558-A720D7BF-854D-45FF-AF9E-EFB6759BA594Q41702839-0904EA2F-2485-4B82-AAEB-C21133995ED7Q42373168-D105EA80-1AB0-43A3-A0B5-CF2E5D410228Q46006826-903BD2C4-BF00-4075-B1FE-89FF12C1580EQ48140061-4ABEED29-1FF4-41B4-99A2-099301D218BD
P2860
Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.
@en
Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.
@nl
type
label
Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.
@en
Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.
@nl
prefLabel
Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.
@en
Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.
@nl
P2860
P356
P1433
P1476
Guideline approach to therapy in patients with newly diagnosed type 2 diabetes.
@en
P2093
Itamar Raz
P2860
P304
P356
10.2337/DCS13-2035
P407
P478
36 Suppl 2
P577
2013-08-01T00:00:00Z